DOWNLOAD and share the WHITE PAPER now The current array of healthcare reforms hasn’t produced a single reimbursement model that can replace our reliance on a fee-for-service (FFS)...
In earlier posts on the new frontier of Molecular Diagnostic testing, I’ve discussed the need for identifying and classifying tests as well as the opportunity and challenges this new technology...
“Changing the future of claims processing.” That’s how ACO News reported McKesson Episode Management’s™ recent release of 22 new episodes based on the PROMETHEUS...
A dramatic rise in spending on molecular diagnostic (MDx) tests, coupled with an inability to identify specific MDx tests submitted on claims, led Palmetto GBA, to initiate the Palmetto MolDX...
Molecular Diagnostics (MDx), the next wave of innovation in healthcare technology, is arriving. Exciting, challenging, transformational, hopeful, complex, alarming, terrifying and expensive are all...
Four Insurers Enroll Nearly 95% Of California Sign-Ups - Kaiser Health News rtag.co/XfQr
Spinal Cord Stimulation Data Show Low Conversion Rate rtag.co/XfQe
Healthcare IT Security Brings Challenges, Opportunities, but No Big Surprises - rtag.co/XfQJ #healthit #hit #security
Hospitals can speed stroke treatment, but it’s not easy rtag.co/XfQW
Genomic Study Reveals Role of Human Papillomavirus in Cervical Cancer | rtag.co/XfQq #genomics
Cost and Quality Improvement
Personalized Medicine/Molecular Diagnostics (MDx)
Point-of-Care Decision Management
Provider Network Management
Waste, Abuse and Fraud Prevention
Fredric Leary, MD
Jacqueline Mitus, MD
Douglas Moeller, MD
David Nace, MD
Emad Rizk, MD
Better Thinking for Better Health